Business Context and Reporting Period
This Form 6-K filing by Lichen International Ltd covers the month ended January 2026. The report details the results of an Extraordinary General Meeting of Shareholders convened on December 30, 2025. The Company is a foreign private issuer headquartered in Xiamen, China, with its principal executive office located at 15th Floor, Xingang Square, Hubin North Road, Siming District.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on corporate governance actions and shareholder voting results rather than financial performance.
Material Changes and Corporate Actions
Shareholders representing 92.23% of the total voting power (15,970,739 voting power) attended the meeting and approved all six proposals. The material changes include:
- Share Capital Increase: Authorized share capital increased from US$1,000,000 to US$200,000,000. This involves creating 19.9 billion additional Series A ordinary shares and 4.975 billion additional Series B ordinary shares.
- Share Consolidation: Approved a consolidation of issued and unissued Series A and Series B ordinary shares at a ratio between 1-for-20 and 1-for-200. The exact ratio and effective date are to be determined by the Board within 18 months.
- Articles of Association Amendments: Adopted changes regarding the requirement for annual general meetings, quorum definitions (lowering the threshold to one-third of voting rights for listed companies), and procedures for adjournment if a quorum is not present.
Guidance, Outlook, and Risks
The filing contains no management commentary on financial guidance, future outlook, or specific risk factors. The primary contingency noted is the Board's discretion to determine the exact share consolidation ratio and effective date within the next 18 months. Proposal Six, regarding the adjournment of the meeting if insufficient votes were obtained, was also approved but was not triggered as all proposals passed.
Investor Verification Checklist
- Verify the exact share consolidation ratio and effective date once determined by the Board within the 18-month window.
- Confirm the impact of the 1-for-20 to 1-for-200 consolidation on the current share price and trading volume.
- Review the filed Exhibit 3.1 (Amended and Restated Memorandum and Articles of Association) for specific legal implications of the quorum and meeting frequency changes.
- Monitor future filings for the actual issuance of the newly authorized shares to determine dilution effects.